HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol

NCT00000799 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Cidofovir
DRUG: Probenecid

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]